Web Stats Provided By Google Analytics

Monday, July 11, 2016

FDA OKs wearable injector for Amgen's Repatha cholesterol drug

... Pharmaceuticals and Sanofi for violating Repatha patents. In October 2014, Amgen sued Paris-based Sanofi and Tarrytown, N.Y.-based Regeneron for violating patents for Repatha after Sanofi and Regeneron co-developed PSK9 inhibitor Praluent to treat ...
http://ift.tt/29CAIp1

No comments:

Post a Comment

Popular Tarrytown Roundup Posts